Literature DB >> 30448276

HLA genotype and response to nivolumab therapy in relapsed refractory primary mediastinal B-cell lymphoma.

Rehab Yassin1, Ali Hajeer2, Saeed Alshieban3, Ghulam Syed4, Bader Alahmari1, Ayman Alhejazi5, Ahmed Alaskar5, Mohsen Alzahrani5, Moussab Damlaj6.   

Abstract

Entities:  

Keywords:  HLA; PD-1 inhibitor; Primary mediastinal B-cell lymphoma

Mesh:

Substances:

Year:  2018        PMID: 30448276     DOI: 10.1016/j.retram.2018.11.001

Source DB:  PubMed          Journal:  Curr Res Transl Med        ISSN: 2452-3186            Impact factor:   4.513


× No keyword cloud information.
  1 in total

Review 1.  Nivolumab plus gemcitabine, dexamethasone, and cisplatin chemotherapy induce durable complete remission in relapsed/refractory primary mediastinal B-cell lymphoma: a case report and literature review.

Authors:  Gang Huang; Ju Huang; Zhili Zhang; Chongchong Xue; Yuan Liu
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.